{"id":"W4415940566","doi":"10.1016/j.annonc.2025.08.2579","title":"1955P SAVANNAH: Safety and tolerability of osimertinib (osi) + savolitinib (savo) in EGFRm advanced NSCLC with MET overexpression and/or amplification (OverExp/Amp) following disease progression on osi","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"AstraZeneca","keywords":"Osimertinib; Tolerability; Disease; Safety profile; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004008948,0.0003028596,0.0005787459,0.0002116507,0.0001895476,0.0004702236,0.00025578,0.0005296178,0.005819783],"category_scores_gemma":[0.0005336837,0.0001633679,0.0007422999,0.0001515651,0.0002897796,0.0004815028,0.0001619244,0.001240183,0.0008366709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004999616,"about_ca_system_score_gemma":0.0005764543,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006882328,"about_ca_topic_score_gemma":0.001459026,"domain_scores_codex":[0.9997975,0.00007525692,0.00001138796,0.00003256865,0.00003316534,0.00005006446],"domain_scores_gemma":[0.9998603,0.00003201321,0.00002986271,0.00001252071,0.000009145097,0.00005601218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4713952,0.01203814,0.01409567,0.0007123735,0.001662278,0.0006634332,0.0001987443,0.002060031,0.11679,0.001264216,0.01027091,0.368849],"study_design_scores_gemma":[0.1767418,0.6061731,0.1144507,0.0002351073,0.002108879,0.002691945,0.0002937705,0.01022011,0.04790138,0.001170222,0.03786179,0.0001511654],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9932917,0.00162835,0.0002752229,0.0003431293,0.0001050367,0.0001304656,0.0005130604,0.0001011858,0.003611835],"genre_scores_gemma":[0.9968124,0.0003753315,0.0002569071,0.0001759514,0.00004897232,0.00007278347,0.0005258329,0.00001329259,0.001718558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005819783,"threshold_uncertainty_score":0.01946914,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04505207697317305,"score_gpt":0.4422815462509395,"score_spread":0.3972294692777664,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}